πŸ‡ΊπŸ‡Έ FDA
Patent

US 10407416

Kappa opioid agonists and uses thereof

granted A61PA61P1/06A61P25/04

Quick answer

US patent 10407416 (Kappa opioid agonists and uses thereof) held by Nektar Therapeutics expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/06, A61P25/04